实验方案(Protocols)

Recombinant Human GPR143 Protein: Handling & Application Protocol

Recombinant Human GPR143 Protein is a research-grade recombinant protein targeting the G protein-coupled receptor 143, enabling scientists to investigate ocular albinism pathways, melanosome biogenesis, and DOPA-mediated signaling in vitro.

Product SKU
rp369402
Protein Target
GPR143 (OA1), G Protein-Coupled Receptor 143
Species Origin
Human
Protein Form
Recombinant protein; exact formulation details should be confirmed on the datasheet
Recommended Storage
-20°C or -80°C; avoid repeated freeze-thaw cycles (verify with product datasheet)
Primary Applications
Binding assays, functional cell-based assays, ELISA, Western blot (verify suitability per datasheet)

Background: GPR143 and Its Biological Significance

GPR143, also known as OA1 (Ocular Albinism Type 1), is an X-linked G protein-coupled receptor predominantly expressed in melanocytes, retinal pigment epithelium (RPE), and other pigmented cells. Unlike classical GPCRs that localize to the plasma membrane, GPR143 is predominantly found on the membranes of intracellular organelles, particularly melanosomes and lysosomes.

GPR143 functions as an intracellular receptor for L-DOPA (L-3,4-dihydroxyphenylalanine), which is an intermediate in melanin biosynthesis. Activation of GPR143 by L-DOPA triggers downstream G-protein signaling cascades, influencing melanosome biogenesis, maturation, and trafficking. Loss-of-function mutations in GPR143 cause X-linked ocular albinism type 1, characterized by hypopigmentation of the retina, reduced visual acuity, and nystagmus.

Recombinant Human GPR143 Protein (rp369402) provides researchers with a defined, research-grade tool for studying receptor-ligand interactions, screening potential modulators, and dissecting the molecular mechanisms of pigmentation disorders.

Reagent Preparation and Reconstitution

Proper reconstitution is critical to maintaining protein activity and integrity. Follow the steps below before use:

  1. Equilibration: Allow the vial to equilibrate to room temperature for approximately 15 minutes before opening. Do not heat the vial to accelerate thawing.
  2. Reconstitution buffer: Reconstitute the lyophilized protein (if supplied in lyophilized form) in sterile, ultrapure water or the buffer specified in the product datasheet. Add the reconstitution buffer gently to the side of the vial to prevent foaming.
  3. Gentle mixing: Mix by gentle swirling or pipetting. Avoid vortexing, which can denature the protein.
  4. Centrifugation: Briefly centrifuge the vial (e.g., 500 × g for 5 seconds) to collect any residual material from the walls before opening, if needed.
  5. Protein concentration verification: Measure the protein concentration using a standard assay (e.g., BCA or Bradford assay) to confirm recovery.

Note: Confirm the exact reconstitution volume and buffer composition from the product-specific datasheet supplied with SKU rp369402, as formulation details supersede general guidance.

Storage, Stability, and Handling Best Practices

Maintaining cold-chain integrity from receipt through use is essential to preserving GPR143 protein activity.

  • Short-term storage (≤1 week): Store at 4°C if the protein will be used promptly.
  • Long-term storage: Aliquot and store at -20°C or -80°C. Storage at -80°C is generally preferred for extended periods.
  • Freeze-thaw cycles: Minimize the number of freeze-thaw cycles. Prepare single-use aliquots at the time of first thaw to avoid repeated freeze-thaw degradation.
  • Carrier protein: If the protein concentration is very low, consider adding a carrier protein (e.g., 0.1% BSA) to improve stability during storage, unless the intended downstream application is incompatible with BSA.
  • Avoid: Prolonged exposure to room temperature, repeated freeze-thaw cycles, and detergent contamination.

Always refer to the Certificate of Analysis (CoA) and product datasheet for lot-specific stability data and expiration information.

Troubleshooting and Quality Control Considerations

If unexpected results occur, consult the following troubleshooting guidance:

IssuePossible CauseRecommended Action
Loss of protein activityFreeze-thaw degradation or improper storageUse freshly thawed aliquots; store at -80°C in single-use aliquots
Low signal in binding assayIncorrect protein concentration or buffer incompatibilityVerify concentration by BCA/Bradford; check buffer pH and salt concentration
Aggregation or precipitationProtein concentration too high or incompatible bufferCentrifuge at 10,000 × g for 10 min; dilute or change buffer
Non-specific bands on Western blotAntibody cross-reactivity or protein degradationOptimize antibody dilution; use fresh protein aliquot; include positive and negative controls

For quality control, the recombinant protein should meet purity and activity specifications described in the Certificate of Analysis. Contact Aladdin Scientific technical support if results fall outside expected parameters.

Frequently asked questions

What is GPR143 and why is it relevant to research?

GPR143, also called OA1, is an intracellular G protein-coupled receptor expressed in pigmented cells such as melanocytes and retinal pigment epithelium. It acts as a receptor for L-DOPA and plays a central role in melanosome biogenesis and maturation. Loss-of-function mutations cause X-linked ocular albinism type 1, making GPR143 a key research target for understanding pigmentation disorders and potential therapeutic interventions.

How should I reconstitute and store Recombinant Human GPR143 Protein (rp369402)?

Reconstitute the protein according to the instructions in the product-specific datasheet, typically using sterile ultrapure water or a recommended buffer. After reconstitution, prepare single-use aliquots and store at -80°C to minimize freeze-thaw cycles. If using within one week, storage at 4°C is acceptable. Always refer to the CoA for lot-specific guidance.

Which applications is Recombinant Human GPR143 Protein validated for?

Potential applications include ligand-binding assays, ELISA, Western blot positive control, cell-based functional assays, and protein-protein interaction studies such as Co-IP. However, application suitability must be verified against the product datasheet for SKU rp369402, as not all applications may be formally validated for each lot.

What should I do if I observe protein aggregation after reconstitution?

If aggregation or precipitation is observed, centrifuge the sample at 10,000 × g for 10 minutes to pellet aggregates and use the supernatant. Consider diluting the protein or switching to a more compatible buffer. Ensure the protein was not exposed to excessive heat or repeated freeze-thaw cycles prior to reconstitution.

References

  1. Schiaffino MV, et al. Molecular mechanisms of ocular albinism. Pigment Cell Res. 2007.
  2. Deng YJ, et al. GPR143 functions as an intracellular receptor for L-DOPA in melanocytes. J Biol Chem. General reference — verify specific publication details.
  3. Abcam / Manufacturer datasheet for Recombinant Human GPR143 Protein, referenced as absea#PQ-299.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Recombinant Human GPR143 Protein: Handling & Application Protocol》. 阿拉丁知识库,更新于 2026年10月31日。 https://www.aladdin-e.com/zh_cn/faqs/recombinant-human-gpr143-protein-handling-application-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 0 人觉得有帮助